XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.2
Segment Information (Sales And Other Financial Information By Business Segment) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Segment Reporting Information [Line Items]        
Net sales $ 5,422 $ 4,996 $ 10,665 $ 9,774
Segment operating income 1,051 965 2,023 1,700
Amortization of intangible assets (155) (161) (308) (322)
MedSurg and Neurotechnology:        
Segment Reporting Information [Line Items]        
Net sales 3,117 2,860 6,116 5,550
Orthopaedics and Spine:        
Segment Reporting Information [Line Items]        
Net sales 2,305 2,136 4,549 4,224
Operating Segments        
Segment Reporting Information [Line Items]        
Segment operating income 1,537 1,381 2,946 2,609
Operating Segments | MedSurg and Neurotechnology:        
Segment Reporting Information [Line Items]        
Net sales 3,117 2,860    
Segment operating income 861 780 1,665 1,407
Operating Segments | Orthopaedics and Spine:        
Segment Reporting Information [Line Items]        
Net sales 2,305 2,136 4,549 4,224
Segment operating income 676 601 1,281 1,202
Corporate and other        
Segment Reporting Information [Line Items]        
Segment operating income (203) (165) (466) (387)
Segment Reconciling Items        
Segment Reporting Information [Line Items]        
Acquisition and integration-related costs (23) (2) (10) (8)
Amortization of intangible assets (155) (161) (308) (322)
Structural optimization and other special charges (75) (72) (89) (114)
Medical device regulations (15) (27) (28) (55)
Recall-related matters (17) (3) (22) (3)
Regulatory and legal matters $ 2 $ 14 $ 0 $ (20)